DS Goodin

868 total citations
9 papers, 482 citations indexed

About

DS Goodin is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, DS Goodin has authored 9 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 3 papers in Neurology and 3 papers in Oncology. Recurrent topics in DS Goodin's work include Multiple Sclerosis Research Studies (7 papers), Peripheral Neuropathies and Disorders (3 papers) and Polyomavirus and related diseases (2 papers). DS Goodin is often cited by papers focused on Multiple Sclerosis Research Studies (7 papers), Peripheral Neuropathies and Disorders (3 papers) and Polyomavirus and related diseases (2 papers). DS Goodin collaborates with scholars based in United States, Canada and United Kingdom. DS Goodin's co-authors include David O. Bates, B. Weinstock‐Guttman, Stephen L. Hauser, Nick Patterson, J. A. Cohen, Jonathan L. Haines, Omar Khan, Ruth Ann Marrie, David V. Glidden and David Reich and has published in prestigious journals such as Neurology, American Journal of Ophthalmology and Annals of Emergency Medicine.

In The Last Decade

DS Goodin

9 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
DS Goodin United States	6	409	132	127	95	94	9	482
Jolijn J Kragt Netherlands	12	382 0.9×	118 0.9×	155 1.2×	64 0.7×	61 0.6×	15	541
Aurora Fuiani Italy	10	465 1.1×	177 1.3×	201 1.6×	127 1.3×	54 0.6×	14	530
Victoria Fernández Spain	13	302 0.7×	82 0.6×	91 0.7×	118 1.2×	93 1.0×	40	483
Elisabetta Verdun di Cantogno United States	11	380 0.9×	139 1.1×	98 0.8×	93 1.0×	38 0.4×	23	437
B. Runmarker Sweden	8	419 1.0×	104 0.8×	137 1.1×	65 0.7×	196 2.1×	9	553
Carrie M. Hersh United States	13	465 1.1×	150 1.1×	111 0.9×	135 1.4×	61 0.6×	51	588
C. A. Vedeler Norway	11	229 0.6×	108 0.8×	72 0.6×	72 0.8×	79 0.8×	13	442
Jacqueline Nicholas United States	12	370 0.9×	110 0.8×	86 0.7×	108 1.1×	67 0.7×	47	507
Salim Chahin United States	14	339 0.8×	158 1.2×	68 0.5×	65 0.7×	44 0.5×	28	460
Hanna Kuusisto Finland	13	249 0.6×	81 0.6×	78 0.6×	126 1.3×	102 1.1×	42	429

Countries citing papers authored by DS Goodin

Since Specialization

Citations

This map shows the geographic impact of DS Goodin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DS Goodin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DS Goodin more than expected).

Fields of papers citing papers by DS Goodin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DS Goodin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DS Goodin. The network helps show where DS Goodin may publish in the future.

Co-authorship network of co-authors of DS Goodin

This figure shows the co-authorship network connecting the top 25 collaborators of DS Goodin. A scholar is included among the top collaborators of DS Goodin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DS Goodin. DS Goodin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Goodin, DS, et al.. (2020). 179 Ethnicity and Symptom Onset in the Emergency Department during the SARS-CoV-2 Pandemic at the “Epicenter of the Epicenter”. Annals of Emergency Medicine. 76(4). S69–S69. 1 indexed citations

Wilson, Leslie, Lixian Zhong, DS Goodin, et al.. (2013). Patient preferences for attributes of disease modifying Therapies: Results of a choice based conjoint analysis. Value in Health. 16(3). A107–A107. 2 indexed citations

Goodin, DS, George C. Ebers, & Gary Cutter. (2013). Cause of death in MS: Longterm follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study (BMJ Open (2012) 2 (e001972)). Oxford University Research Archive (ORA) (University of Oxford). 1 indexed citations

Reder, Anthony T., George C. Ebers, Anthony Traboulsee, et al.. (2010). Cross-sectional study assessing long-term safety of interferon-β-1b for relapsing-remitting MS. Neurology. 74(23). 1877–1885. 48 indexed citations

Goodin, DS & David O. Bates. (2009). Review: Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode. Multiple Sclerosis Journal. 15(10). 1175–1182. 68 indexed citations

Goodin, DS, Bruce A. Cohen, Paul O’Connor, Ludwig Kappos, & J. Clarke Stevens. (2008). Assessment: The use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review). Neurology. 71(10). 766–773. 81 indexed citations

Goodin, DS, Barrie J. Hurwitz, & Avertano Noronha. (2007). Neutralizing Antibodies to Interferon β-1b are not Associated with Disease Worsening in Multiple Sclerosis. Journal of International Medical Research. 35(2). 173–187. 21 indexed citations

Cree, Bruce, Omar Khan, Dennis Bourdette, et al.. (2004). Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology. 63(11). 2039–2045. 242 indexed citations

Goodin, DS, Peter A. Calabresi, Massimo Filippi, et al.. (2004). The utility of MRI in suspected MS: report of the Therapeutics and technology assessment Subcommittee of the American Academy of Neurology. American Journal of Ophthalmology. 137(2). 390–391. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact